Volume 9, Issue 4, Pages (April 2016)

Slides:



Advertisements
Similar presentations
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Advertisements

Yuming Lu, Jian-Kang Zhu  Molecular Plant 
by S. Kangsadalampai, and P.G. Board
A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures  Gang Wang, Na Zhao, Ben Berkhout, Atze.
Dan Ding, Kaiyuan Chen, Yuedan Chen, Hong Li, Kabin Xie 
Volume 8, Issue 8, Pages (August 2015)
Volume 8, Issue 12, Pages (December 2015)
Philippe Szankasi, Mohamed Jama, David W. Bahler 
Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9
Catherine E. Keegan, Anthony A. Killeen 
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Rapid Decoding of Sequence-Specific Nuclease-Induced Heterozygous and Biallelic Mutations by Direct Sequencing of PCR Products  Xingliang Ma, Letian Chen,
Volume 154, Issue 6, Pages (September 2013)
Volume 22, Issue 1, Pages (January 2018)
Volume 7, Issue 1, Pages (April 2014)
Molecular Therapy - Nucleic Acids
Volume 11, Issue 4, Pages (April 2018)
Expanding the Scope of CRISPR/Cpf1-Mediated Genome Editing in Rice
Molecular Therapy - Nucleic Acids
Trans-Splicing to Spliceosomal U2 snRNA Suggests Disruption of Branch Site-U2 Pairing during Pre-mRNA Splicing  Duncan J. Smith, Charles C. Query, Maria.
Therapeutic editing of hepatocyte genome in vivo
Volume 7, Issue 3, Pages (September 2016)
Structure of the GM2A Gene: Identification of an Exon 2 Nonsense Mutation and a Naturally Occurring Transcript with an In-Frame Deletion of Exon 2  Biao.
RNA-Guided Genome Editing in Plants Using a CRISPR–Cas System
Molecular Therapy - Nucleic Acids
Volume 10, Issue 8, Pages (August 2017)
Volume 154, Issue 6, Pages (September 2013)
A Multi-Exonic BRCA1 Deletion Identified in Multiple Families through Single Nucleotide Polymorphism Haplotype Pair Analysis and Gene Amplification with.
Volume 10, Issue 7, Pages (July 2017)
Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts
Volume 153, Issue 4, Pages (May 2013)
Current Progress in Therapeutic Gene Editing for Monogenic Diseases
Revolutionize Genetic Studies and Crop Improvement with High-Throughput and Genome-Scale CRISPR/Cas9 Gene Editing Technology  Ning Yang, Rongchen Wang,
Expression of a microRNA-Resistant Target Transgene Misrepresents the Functional Significance of the Endogenous microRNA: Target Gene Relationship  Junyan.
RAD51 is essential for L. donovani.
Volume 11, Issue 4, Pages (April 2018)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases  Li Xu, Piming Zhao, Andrew Mariano, Renzhi.
Volume 25, Issue 11, Pages (November 2017)
Volume 12, Issue 9, Pages (September 2015)
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
Volume 2, Issue 1, Pages (January 2014)
Novel Polymorphism in the FMR1 Gene Resulting in a “Pseudodeletion” of FMR1 in a Commonly Used Fragile X Assay  Thomas M. Daly, Arash Rafii, Rick A. Martin,
Zhao Zhang, Yuelin Zhang, Fei Gao, Shuo Han, Kathryn S
Molecular Therapy - Methods & Clinical Development
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Volume 153, Issue 4, Pages (May 2013)
Molecular Therapy - Nucleic Acids
Expanding the Range of CRISPR/Cas9 Genome Editing in Rice
Volume 10, Issue 1, Pages (January 2017)
Genome-wide Targeted Mutagenesis in Rice Using the CRISPR/Cas9 System
Volume 25, Issue 2, Pages (February 2017)
Molecular Therapy - Nucleic Acids
Volume 23, Issue 3, Pages (March 2015)
Assessing the Functional Characteristics of Synonymous and Nonsynonymous Mutation Candidates by Use of Large DNA Constructs  A.M. Eeds, D. Mortlock, R.
Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii. Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii.
Volume 6, Issue 4, Pages (July 2013)
Volume 17, Issue 2, Pages (August 2015)
Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence replacement. Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence.
Anthony M. Raizis, Martin M. Ferguson, David T. Nicholls, Derek W
Volume 9, Pages (November 2018)
Volume 13, Issue 3, Pages (October 2015)
Volume 26, Issue 11, Pages (November 2018)
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
Recombination of a Cas9-created DNA fragment with and without end repair. Recombination of a Cas9-created DNA fragment with and without end repair. (A)
Fang Wang, Yunfeng Wang, Jie Ding, Jiyun Yang  Kidney International 
Genome-Edited Triple-Recessive Mutation Alters Seed Dormancy in Wheat
Volume 27, Issue 13, Pages e4 (June 2019)
Fig. 3 Genome editing of the MSTN gene.
Presentation transcript:

Volume 9, Issue 4, Pages 628-631 (April 2016) Engineering Herbicide-Resistant Rice Plants through CRISPR/Cas9-Mediated Homologous Recombination of Acetolactate Synthase  Yongwei Sun, Xin Zhang, Chuanyin Wu, Yubing He, Youzhi Ma, Han Hou, Xiuping Guo, Wenming Du, Yunde Zhao, Lanqin Xia  Molecular Plant  Volume 9, Issue 4, Pages 628-631 (April 2016) DOI: 10.1016/j.molp.2016.01.001 Copyright © 2016 The Author Terms and Conditions

Figure 1 Generation of Herbicide-Resistant Rice Plants through CRISPR/Cas9-Mediated Homologous Recombination of Acetolactate Synthase. (A) A schematic description of the wild-type ALS gene. Note that the locations of target 1, target 2, and the arms are indicated. Target 1 and target 2 are recognized by gRNA1 and gRNA2, respectively. The left and right arms were 100 bp and 46 bp in length, respectively. (B) Linearized construct that was designed to produce Cas9 protein, two gRNAs, and both the donor fragment in the vector and the free donor fragment containing several mutated sites that confer W548L and S627I substitutions. The sequences of mutated target 1, mutated target 2, and the EcoRV site were modified into desired synonymous nucleotides in the donor. (C) PCR products amplified by primers 753F/R were digested with EcoRV. M, DL2000; WT, wild-type. EcoRV cut the PCR products of wild-type, resulting in 488-bp and 265-bp fragments. EcoRV failed to digest the PCR products from eight lines. B99-9 and B99-12 plants appeared to be heterozygous. After EcoRV digestion of the PCR products from B99-9 and B99-12, four fragments (488 bp, 424 bp, 331 bp, and 265 bp) were observed. (D) The sequences of different HDR types. (E) The sequences of two clones from the B99-12 plant. The DSBs were repaired by inserting a DNA fragment that was the reverse complement to the wild-type sequences. Note that the junction sequences are marked with different matching colors. Such insertion would generate two EcoRV fragments (424 bp and 331 bp) (as shown in Figure 1C). The numbers flanking the EcoRV site refer to the distances between the listed sequences. (F) Chromatograms of HDR of the modified ALS gene in the desired region. (G) The plants shown were 36 days after being sprayed with 100 μM bispyribac sodium at the five-leaf stage. The lines on the left side were rice plants with the edited ALS gene and the lines on the right side were wild-type rice plants. Note that wild-type plants died while the edited plants grew normally. For (A, D–F), the gRNA targeting sequences are underlined, and the PAM sequences are boxed. WT ALS refers to the wild-type ALS gene sequence. Differences between the donor sequence and the wild-type ALS gene sequence are shadowed. Molecular Plant 2016 9, 628-631DOI: (10.1016/j.molp.2016.01.001) Copyright © 2016 The Author Terms and Conditions